# Xisoft

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xisoft

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Website: www.xisofttec.com
- Total disclosed funding: $46M
- Latest round: Series C (May 21, 2024)
- Investors on record: 7

## About

Based in Shanghai, China and established in 2018, Xisoft is a software company that focuses on the operation and management of digital intelligence in health care industry. It was recognized as the National High-tech Enterprise. The company acquired certifications such as ITSS information technology service, CCRC information security service, and ISO9001 quality management system, etc. Xisoft has 3 R&D centers in Beijing, Shanghai and Xi'an, with branch offices in Guangdong, Sichuan, and other provinces and cities. Xisoft has more than 30 software products with independent intellectual property rights. Chong Chen, the founder and CEO of the company, has 20 years of working experience in ERP and HRP field. In April 2024, Xisoft closed a series C funding.

The company engages in the research and development of intelligent operation management system for hospital. Its main products include hospital intelligent operation management systems (HRP), operation data centers (ODR), health economic supervision cloud, etc. Operations Management System HRP provides accounting, asset management, budget management and contract management services. Products have served general and specialized hospitals, as well as health administrative authorities in China.

The company’s revenue is generated by providing digital intelligence services for operations management in the healthcare industry.

The company will use the funding for the development of the Hospital Operation Data Center (ODR) product and the development and promotion of artificial intelligence products and applications, as well as the digital transformation of the healthcare industry.

## Funding rounds

- Series C, May 21, 2024 — SAIF Partners, Shunwei Capital
- Series B, Mar 4, 2022, $16M — Hong Shan, Gaorong Ventures, Everest VC, Taikang Life Insurance
- Series A, May 27, 2021, $16M — Hong Shan, Gaorong Ventures, Sherpa Healthcare Partners
- Series A, Sep 23, 2020, $15M — Gaorong Ventures, Sherpa Healthcare Partners

## Investors

- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Series A, Series B
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A
- Hong Shan — Series A, Series B
- Everest VC (https://capitalatlas.ai/funds/everest-vc) — Series B
- Taikang Life Insurance — Series B
- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series C
- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Series C